Negative impact of anorexia and weight loss during prior pirfenidone administration on subsequent nintedanib treatment in patients with idiopathic pulmonary fibrosis.

BMC Pulm Med · 2019 · PMC6458823 · PMID 30975118

Europe PMC DOI

hedged sentence

0.0720

closest p · 1.4× alpha

0.0720

boldest claim

The sentences

did not reach statistical significancep = 0.0720so close (0.05 < p ≤ 0.1)

The proportion of discontinuation of nintedanib within 6 months was also higher in the switch-group than in the pirfenidone-naïve group, although this difference did not reach statistical significance ( p = 0.0720).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.